Abstract:Background Novel psychoactive substances (NPS) are a group of substances, mainly of synthetic origin, characterized by toxicological properties extremely dangerous. The main difficulty in recognizing NPS in seizures and biological samples lies in their dynamic nature, related to the continuous synthesis and introduction on the market of new drugs, often with very similar structures to existing ones. The aim of this study was the creation of a robust and versatile method for the analysis of traditional drugs and NPS in different matrices. Results Both target analysis and suspect screening methodologies were developed. The strategy used for suspect screening allowed to collect data through a scheduled multi reaction monitoring (sMRM) survey which triggered the collection of enhanced product ion (EPI) spectra when a compound met information dependent acquisition (IDA) criteria. The retention time of the different drugs, which was crucial to define the sMRM survey scan parameters, was predicted with a Quantitative Structure Retention (Chromatographic) Relationship (QSRR) model by Multiple Linear Regression. The model was validated through the evaluation of training set predictions, an external validation set and a leave-one out strategy; the results showed that the method fit for its purpose. The target method was validated in oral fluid as a testing matrix, with excellent results in term of recovery, accuracy, precision and matrix effect. Finally, the performances of the suspect method were evaluated by analysing a mixture containing 8 reference standards not included in the initial dataset, as well as seizures and real oral fluid samples. Four NPS were putatively identified in the analysed samples. Significance The advantage of the proposed approach is the possibility of quantifying 65 classical drugs of abuse and NPS and, at the same time, detect and putatively identify 146 additional drugs in one single LC-MS/MS run. This is an innovative strategy for multi analyte detection and enables detection of low concentrations of drugs in complex biological matrices such as oral fluid. Considering the highly dynamic drug market, a strength of this strategy is that the analytical method can be kept up to date through the addition of new compounds based on the last drug monitoring bodies alerts without the need of authentic standards.

Deep Learning-Enabled MS/MS Spectrum Prediction Facilitates Automated Identification Of Novel Psychoactive Substances

Identification of Emerging Novel Psychoactive Substances by Retrospective Analysis of Population-Scale Mass Spectrometry Data Sets

Machine Learning-Assisted Rapid Screening of Four Types of New Psychoactive Substances in Drug Seizures.

A field-portable technology for illicit drug discrimination via deep learning of hybridized reflectance/fluorescence spectro-scopic fingerprints

A deep generative model enables automated structure elucidation of novel psychoactive substances

Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review

Deep learning-assisted mass spectrometry imaging for preliminary screening and pre-classification of psychoactive substances

ATR-FTIR combined with machine learning for the fast non-targeted screening of new psychoactive substances

Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering

Workflow to facilitate the detection of new psychoactive substances and drugs of abuse in influent urban wastewater

Rapid Screening and Determination of 11 New Psychoactive Substances by Direct Analysis in Real Time Mass Spectrometry and Liquid Chromatography/quadrupole Time-of-flight Mass Spectrometry.

Classification of Mass Spectral Data to Assist in the Identification of Novel Synthetic Cannabinoids

A point-of-need framework for illicit drug identification with high-resolution mass spectrometry

Identification of Synthetic Drugs on Seized Blotter Papers Using ATR-FTIR and PLS-DA: Routine Application in a Forensic Laboratory

Guilty by dissociation—development of gas chromatography–mass spectrometry (GC-MS) and other rapid screening methods for the analysis of 13 diphenidine-derived new psychoactive substances (NPSs)

Advancing the Prediction of MS/MS Spectra Using Machine Learning

Machine learning methods for classifying novel fentanyl analogs from Raman spectra of pure compounds

AddictedChem: A Data-Driven Integrated Platform for New Psychoactive Substance Identification

Molecular Networking: A Useful Tool for the Identification of New Psychoactive Substances in Seizures by LC–HRMS

Recent advances in analysis of new psychoactive substances by means of liquid chromatography coupled with low-resolution tandem mass spectrometry

Target and suspect screening of psychoactive substances in seizures and oral fluid exploiting retention time prediction and LC-MS/MS analysis